Business News/Market/Market Stats/   Sun Pharmaceutical Industries Q2 Results

Sun Pharmaceutical Industries Q2 Results

BSE: 524715 | NSE: SUNPHARMA | ISIN: INE044A01036 | Sector: Biotechnology & Drugs
1,191.40 -5.00 (-0.42%)Updated : 28 Nov 2023
Fiscal Period2024
Period End DateSep 23
Revenue 12192.41
Total Revenue 12192.41
Costof Revenue Total 2787.09
Gross Profit 9405.32
Selling/ General/ Admin Expenses Total 2364.36
Depreciation/ Amortization 632.82
Unusual Expense( Income) 0.00
Other Operating Expenses Total 3827.49
Total Operating Expense 9611.76
Operating Income 2580.65
Interest Inc( Exp) Net- Non- Op Total -833.80
Other Net 293.61
Net Income Before Taxes 2790.88
Provisionfor Income Taxes 390.10
Net Income After Taxes 2400.78
Minority Interest -9.59
Equity In Affiliates -156.80
Net Income Before Extra Items 2375.51
Net Income 2375.51
Income Availableto Com Excl Extra Ord 2375.51
Income Availableto Com Incl Extra Ord 2375.51
Diluted Net Income 2375.51
Diluted Weighted Average Shares 239.95
Diluted EPS Excluding Extra Ord Items 9.90
DPS- Common Stock Primary Issue 0.00
Diluted Normalized EPS 9.90
*All figures in crores except per share values
Recommended For You